Acino International AG

Industry

  • Pharmaceuticals
    • OTC, Consumer
    • Drug Delivery
      • Controlled Release
    • Generic Drugs
  • Contract Manufacturing Organization

Other Names/Subsidiaries

  • Acino Holding AG
  • M8 Pharmaceuticals
See more in Biomedtracker

Latest on Acino International AG

Scrip

Asia Deal Watch: Otsuka’s Taiho Licenses LSD1 Inhibitor Rights To Benz

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, Vibha Ravi, and Sushmita Panda

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Taiho Sends Benz LSD1 Inhibitor Fo

Scrip

Deal Watch: Lilly Partners With OpenAI On Drug-Resistant Pathogens

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly The Latest Pharma Company To Sign

Scrip

Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Gilgamesh To Investigate Potent

Generics Bulletin

Off-Patent Personnel Moves In 2023 Reflect Growing Interest In Innovator Space

 
• By Chloe Kent

Executive changes in the off-patent medicines industry throughout 2023 reflected a growing interest in the innovator side of the life sciences sector among leading generics and biosimilars companies.